drugset / Trial / NCT03822767
A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a "2+1"Sequential Schedule With bOPV in Infants
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this phrase III clinical trial is to evaluate the immunogenicity and safety of Sabin Inactivated Poliovirus Vaccine (Vero cell) in a '2+1'sequential schedule with bivalent oral poliovirus vaccine in 2-month-old infants
Timeline
- Start
- 2018-06-12
- Primary completion
- 2018-09-20
- Completion
- 2018-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sabin strain inactivated poliovirus vaccine (Vero cell) | Vaccine | 0.5 ml | Intramuscular |
| Subject | wIPV | Unknown | 0.5 ml | Intramuscular |
| Background | poliovirus (Live) vaccine type I \& type III (Human Diploid cell) | Vaccine | 0.1 ml | Oral |